The survey also suggests that Medicaid is broadly popular amongst all Americans, regardless of political affiliation.

Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical ...

We’re going to tariff our pharmaceuticals, and once we do that, they are going to come rushing back into our country," ...

Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm ...

Results from the Phase III SPACE trial show that Ajovy significantly reduced monthly migraines in pediatric patients between ...

Family caregivers with both children and elderly family members to care for are reporting higher levels of burnout and mental ...

ProFuse Technology is a company focused on the development of muscle tissue in laboratory settings. The company recently ...

Enrollment for the Phase II trial follows FDA clearance of SPG302 Investigational New Drug application for schizophrenia.

Amy Hessels, vice president of marketing, Bayer, discusses how its Your Decision campaign tackles misinformation about reproductive health by providing the information to empower women to discuss ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, talks about Takeda's aims to expand its efforts globally by adapting strategies to regional needs.

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, particularly in phase III psoriasis trials.